Notice of Proposed Sale · 144
Jazz Pharmaceuticals plc
JAZZNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Jazz Pharmaceuticals Plc
- Issuer CIK
- 0001232524
- SEC file number
- 001-33500
- Phone
- 353-1-634-7800
- Person for whose account securities are to be sold
- Bruce C Cozadd
- Relationships to issuer
- Officer
- Street
- 5th Floor Waterloo Exchange
- Street (continued)
- Waterloo Road
- City
- Dublin
- State / country code
- L2
- Postal code
- D04 E5W7
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 6,000 | 1,381,980 | 64,914,577 | 10/01/2026 | NASDAQ | Merrill Lynch |
Broker / market maker — proposed row 1, entry 1
- Name
- Merrill Lynch
- Street
- 3075A Hansen Way 1st Floor
- City
- Palo Alto
- State / country code
- CA
- Postal code
- 94304
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 03/01/2018 | Stock Option | Jazz Pharmaceuticals PLC | 4,393 | N | 03/01/2018 | Cash |
| Common | 03/05/2025 | Stock Option | Jazz Pharmaceuticals PLC | 1,607 | N | 03/05/2025 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Bruce Cozadd | Common | 09/01/2026 | 6,000 | 1,500,780 |
| Bruce Cozadd | Common | 08/03/2026 | 6,000 | 1,517,880 |
| Bruce Cozadd | Common | 07/01/2026 | 6,000 | 1,442,820 |
Seller — prior-sale row 1, entry 1
- Name
- Bruce Cozadd
- Street
- 5th Floor Waterloo Exchange
- Street (continued)
- Waterloo Road
- City
- Dublin
- State / country code
- L2
- Postal code
- D04-E5W7
Seller — prior-sale row 2, entry 1
- Name
- Bruce Cozadd
- Street
- 5th Floor Waterloo Exchange
- Street (continued)
- Waterloo Road
- City
- Dublin
- State / country code
- L2
- Postal code
- D04-E5W7
Seller — prior-sale row 3, entry 1
- Name
- Bruce Cozadd
- Street
- 5th Floor Waterloo Exchange
- Street (continued)
- Waterloo Road
- City
- Dublin
- State / country code
- L2
- Postal code
- D04-E5W7
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 10/01/2026
- Signed
- Bruce C Cozadd
- Plan adoption dates
- 11/26/2025
Company context
global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease - often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.